{"id":118013,"date":"2026-03-10T05:32:26","date_gmt":"2026-03-10T08:32:26","guid":{"rendered":"https:\/\/tech.einnews.com\/article\/898455642\/prn7dyrV_vUMMF1g"},"modified":"2026-03-10T05:32:26","modified_gmt":"2026-03-10T08:32:26","slug":"georgia-tech-receives-up-to-21-8m-award-in-unprecedented-push-to-treat-lymphatic-disease","status":"publish","type":"post","link":"https:\/\/new7.shop\/zerocostfreehost\/index.php\/2026\/03\/10\/georgia-tech-receives-up-to-21-8m-award-in-unprecedented-push-to-treat-lymphatic-disease\/","title":{"rendered":"Georgia Tech Receives Up to $21.8M Award in ‘Unprecedented’ Push to Treat Lymphatic Disease"},"content":{"rendered":"
<\/div>\n

Newswise \u2014 The Georgia Institute of Technology has been awarded up to $21.8 million from the Advanced Research Projects Agency for Health (ARPA-H)<\/a> to deliver a first-of-its-kind therapy to patients with lymphatic disease.<\/p>\n

For many of these patients, care has long meant pain and disfigurement alongside other severe side effects, rather than receiving treatment that addresses the disease itself. This new ARPA-H award marks a potential turning point.<\/p>\n

Lead researcher Susan Napier Thomas<\/a>, Woodruff Professor in the George W. Woodruff School of Mechanical Engineering<\/a> and the Parker H. Petit Institute of Bioengineering and Bioscience<\/a> (IBB), has collaborated with her colleague J. Brandon Dixon<\/a>, Woodruff Professor in the Woodruff School and IBB, for more than a decade on this project. The research partners are driven by the lack of meaningful treatment options available to patients.<\/p>\n

\u201cFunding support at this level is unprecedented,\u201d Thomas said. \u201cIt finally gives us a chance to move beyond symptom management and toward real treatment. We\u2019re addressing an underserved population with a huge unmet need.\u201d <\/p>\n

A Gap in Care<\/h2>\n

The lymphatic system helps keep fluid moving through the body and plays a key role in immune health. When it does not function properly, fluid can build up in tissues, causing chronic pain and other long-term complications. Thomas noted that despite its toll on patients, lymphatic disease has lagged decades behind cardiovascular care in both treatment and research investment. <\/p>\n

\u201cWe are excited about this groundbreaking project in lymphatic engineering,\u201d said Andr\u00e9s Garc\u00eda,<\/a> IBB executive director. \u201cBy uniting interdisciplinary expertise, this work addresses long-standing challenges in lymphatic disease and moves meaningful solutions closer to the patients who need them most.\u201d<\/p>\n

What Comes Next<\/h2>\n

In the coming years, Thomas, Dixon, and their research partners will work toward an initial human trial, with an early focus on rare lymphatic conditions in children, as well as chronic disease in adults.<\/p>\n

\u201cThis award reflects Georgia Tech\u2019s growing leadership in using engineering to solve some of healthcare\u2019s biggest challenges,\u201d said Carolyn Seepersad<\/a>, Eugene C. Gwaltney Jr. School Chair and professor in the Woodruff School. \u201cIt reinforces the Institute\u2019s role in advancing innovations that improve patient care and strengthen Georgia\u2019s position as a hub for health technology and biomedical innovation.\u201d<\/p>\n

The award was made through ARPA-H\u2019s Groundbreaking Lymphatic Interventions and Drug Exploration (GLIDE<\/a>) program led by Dr. Kimberley Steele.<\/p>\n

This research was funded, in part, by the Advanced Research Projects Agency for Health (ARPA-H) under Agreement No. 1AY2AX000137-01. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the U.S. government.<\/em><\/p>\n

<\/a><\/strong> <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Newswise \u00e2\u0080\u0094 The Georgia Institute of Technology<\/span> has been awarded up to … adults. \u00e2\u0080\u009cThis award reflects Georgia Tech<\/span>\u00e2\u0080\u0099s growing leadership in using … position as a hub for health technology<\/span> and biomedical innovation.\u00e2\u0080\u009d The award was …<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-118013","post","type-post","status-publish","format-standard","hentry","category-news","wpcat-1-id"],"_links":{"self":[{"href":"https:\/\/new7.shop\/zerocostfreehost\/index.php\/wp-json\/wp\/v2\/posts\/118013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/new7.shop\/zerocostfreehost\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/new7.shop\/zerocostfreehost\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/new7.shop\/zerocostfreehost\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/new7.shop\/zerocostfreehost\/index.php\/wp-json\/wp\/v2\/comments?post=118013"}],"version-history":[{"count":0,"href":"https:\/\/new7.shop\/zerocostfreehost\/index.php\/wp-json\/wp\/v2\/posts\/118013\/revisions"}],"wp:attachment":[{"href":"https:\/\/new7.shop\/zerocostfreehost\/index.php\/wp-json\/wp\/v2\/media?parent=118013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/new7.shop\/zerocostfreehost\/index.php\/wp-json\/wp\/v2\/categories?post=118013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/new7.shop\/zerocostfreehost\/index.php\/wp-json\/wp\/v2\/tags?post=118013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}